OFIX241115P30000
- 0.00
- 0.000.00%
Orthofix Medical Newsroom
Orthofix to Participate in Stifel 2024 Healthcare Conference
Trauma Fixation Device Research Report and Company Analysis 2024-2032 Featuring Zimmer Biomet, Orthofix Medical, B. Braun Meslungen, Stryker, Medtronic, Smith & Nephew, Integra LifeSciences, & Otto - ResearchAndMarkets.com
Press Release: Orthofix to Report Third Quarter 2024 Financial Results
Orthofix to Report Third Quarter 2024 Financial Results
Orthofix Highlights New Products and Announces Presentation of Data Supporting the Adjunct Use of Bone Growth Therapy for Lumbar Spine Fusion at North American Spine Society Annual Meeting
Orthofix Medical Inc (NASDAQ:OFIX) A Bull Case Theory
Express News | Patrick Fisher Joins Orthofix as President of Global Orthopedics Business
Earnings Call: Orthofix Medical Sees Growth, Raises Full-year Guidance
Q2 2024 Orthofix Medical Inc Earnings Call
JMP Securities Maintains Orthofix Medical(OFIX.US) With Hold Rating
JMP Securities analyst David Turkaly maintains $Orthofix Medical(OFIX.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 39.2% and a total average return of -3.4%
Earnings Call Summary | Orthofix Medical(OFIX.US) Q2 2024 Earnings Conference
Orthofix Medical Inc. (OFIX) Q2 2024 Earnings Call Transcript
Orthofix Medical | 10-Q: Q2 2024 Earnings Report
Orthofix Medical 2Q Sales $198.6M >OFIX
Express News | Orthofix Medical Inc FY2024 Rev View $793.8 Mln -- LSEG IBES Data
Express News | Orthofix Medical Inc- Qtrly Shr Loss $0.88
Express News | Orthofix Medical Inc - Increases Full-Year 2024 Net Sales Guidance to $795 Mln to $800 Mln
Express News | Orthofix Reports Second Quarter 2024 Results and Raises Full-Year 2024 Financial Guidance
Express News | Orthofix Medical Q2 Sales USD 198.6 Million Vs. IBES Estimate USD 195.2 Million
Express News | Orthofix Medical Q2 Gross Margin 67.8%